Combined nimotuzumab with chemoradiotherapy in patients with locally advanced or metastatic esophageal squamous cell carcinoma: A retrospective study
Aims: To observe the efficacy and toxicities of combined nimotuzumab with chemoradiotherapy as the first-line treatment to advanced esophageal squamous cell carcinoma (ESCC). Methods: The clinical data of 43 patients with local advanced or metastatic ESCC treated with nimotuzumab combined with chemo...
|Main Authors:||, , , , , ,|
Wolters Kluwer Medknow Publications
|Series:||Journal of Cancer Research and Therapeutics|